398 related articles for article (PubMed ID: 31053162)
1. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
O'Geen H; Bates SL; Carter SS; Nisson KA; Halmai J; Fink KD; Rhie SK; Farnham PJ; Segal DJ
Epigenetics Chromatin; 2019 May; 12(1):26. PubMed ID: 31053162
[TBL] [Abstract][Full Text] [Related]
2. dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression.
O'Geen H; Ren C; Nicolet CM; Perez AA; Halmai J; Le VM; Mackay JP; Farnham PJ; Segal DJ
Nucleic Acids Res; 2017 Sep; 45(17):9901-9916. PubMed ID: 28973434
[TBL] [Abstract][Full Text] [Related]
3. Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing.
O'Geen H; Tomkova M; Combs JA; Tilley EK; Segal DJ
Nucleic Acids Res; 2022 Apr; 50(6):3239-3253. PubMed ID: 35234927
[TBL] [Abstract][Full Text] [Related]
4. Efficient Targeted DNA Methylation with dCas9-Coupled DNMT3A-DNMT3L Methyltransferase.
Bashtrykov P; Rajaram N; Jeltsch A
Methods Mol Biol; 2023; 2577():177-188. PubMed ID: 36173573
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of the CRISPR/dCas9-EZH2 system for targeted H3K27Me3 modification.
Chen X; Wei M; Liu X; Song S; Wang L; Yang X; Song Y
Biochem Biophys Res Commun; 2019 Apr; 511(2):246-252. PubMed ID: 30795863
[TBL] [Abstract][Full Text] [Related]
6. Repurposing the CRISPR-Cas9 system for targeted DNA methylation.
Vojta A; Dobrinić P; Tadić V; Bočkor L; Korać P; Julg B; Klasić M; Zoldoš V
Nucleic Acids Res; 2016 Jul; 44(12):5615-28. PubMed ID: 26969735
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system.
Josipović G; Tadić V; Klasić M; Zanki V; Bečeheli I; Chung F; Ghantous A; Keser T; Madunić J; Bošković M; Lauc G; Herceg Z; Vojta A; Zoldoš V
Nucleic Acids Res; 2019 Oct; 47(18):9637-9657. PubMed ID: 31410472
[TBL] [Abstract][Full Text] [Related]
8. Ectopic DNMT3L triggers assembly of a repressive complex for retroviral silencing in somatic cells.
Kao TH; Liao HF; Wolf D; Tai KY; Chuang CY; Lee HS; Kuo HC; Hata K; Zhang X; Cheng X; Goff SP; Ooi SK; Bestor TH; Lin SP
J Virol; 2014 Sep; 88(18):10680-95. PubMed ID: 24991018
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases.
Lin L; Liu Y; Xu F; Huang J; Daugaard TF; Petersen TS; Hansen B; Ye L; Zhou Q; Fang F; Yang L; Li S; Fløe L; Jensen KT; Shrock E; Chen F; Yang H; Wang J; Liu X; Xu X; Bolund L; Nielsen AL; Luo Y
Gigascience; 2018 Mar; 7(3):1-19. PubMed ID: 29635374
[TBL] [Abstract][Full Text] [Related]
10. Targeted in vivo epigenome editing of H3K27me3.
Fukushima HS; Takeda H; Nakamura R
Epigenetics Chromatin; 2019 Mar; 12(1):17. PubMed ID: 30871638
[TBL] [Abstract][Full Text] [Related]
11. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements.
Thakore PI; D'Ippolito AM; Song L; Safi A; Shivakumar NK; Kabadi AM; Reddy TE; Crawford GE; Gersbach CA
Nat Methods; 2015 Dec; 12(12):1143-9. PubMed ID: 26501517
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
Kantor B; Tagliafierro L; Gu J; Zamora ME; Ilich E; Grenier C; Huang ZY; Murphy S; Chiba-Falek O
Mol Ther; 2018 Nov; 26(11):2638-2649. PubMed ID: 30266652
[TBL] [Abstract][Full Text] [Related]
13. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing.
Moses C; Hodgetts SI; Nugent F; Ben-Ary G; Park KK; Blancafort P; Harvey AR
Sci Rep; 2020 Jul; 10(1):11393. PubMed ID: 32647121
[TBL] [Abstract][Full Text] [Related]
15. Protein engineering strategies for improving the selective methylation of target CpG sites by a dCas9-directed cytosine methyltransferase in bacteria.
Xiong T; Rohm D; Workman RE; Roundtree L; Novina CD; Timp W; Ostermeier M
PLoS One; 2018; 13(12):e0209408. PubMed ID: 30562388
[TBL] [Abstract][Full Text] [Related]
16. Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation.
Rush M; Appanah R; Lee S; Lam LL; Goyal P; Lorincz MC
Epigenetics; 2009 Aug; 4(6):404-14. PubMed ID: 19717977
[TBL] [Abstract][Full Text] [Related]
17. A review on CRISPR/Cas-based epigenetic regulation in plants.
Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
[TBL] [Abstract][Full Text] [Related]
18. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
[TBL] [Abstract][Full Text] [Related]
19. Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing.
Amabile A; Migliara A; Capasso P; Biffi M; Cittaro D; Naldini L; Lombardo A
Cell; 2016 Sep; 167(1):219-232.e14. PubMed ID: 27662090
[TBL] [Abstract][Full Text] [Related]
20. Efficient targeted DNA methylation with chimeric dCas9-Dnmt3a-Dnmt3L methyltransferase.
Stepper P; Kungulovski G; Jurkowska RZ; Chandra T; Krueger F; Reinhardt R; Reik W; Jeltsch A; Jurkowski TP
Nucleic Acids Res; 2017 Feb; 45(4):1703-1713. PubMed ID: 27899645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
